| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,982 |
5,770 |
$313K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,981 |
2,876 |
$283K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,033 |
5,075 |
$196K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,726 |
1,725 |
$144K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,711 |
1,710 |
$143K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,318 |
1,313 |
$103K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
822 |
822 |
$75K |
| 90461 |
|
1,876 |
1,869 |
$72K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,182 |
1,173 |
$61K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
5,891 |
5,884 |
$53K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
580 |
579 |
$43K |
| 99050 |
|
2,205 |
2,176 |
$37K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,238 |
3,204 |
$35K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,459 |
4,373 |
$33K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,017 |
1,015 |
$30K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
939 |
931 |
$25K |
| 96127 |
|
2,324 |
2,323 |
$24K |
| 99177 |
|
1,114 |
1,113 |
$21K |
| 36416 |
|
1,946 |
1,902 |
$19K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
618 |
616 |
$19K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
618 |
616 |
$19K |
| 99188 |
|
452 |
451 |
$12K |
| 83655 |
|
753 |
752 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
422 |
422 |
$9K |
| 81003 |
|
2,585 |
2,534 |
$5K |
| 80061 |
Lipid panel |
403 |
390 |
$5K |
| 0071A |
|
89 |
89 |
$4K |
| 0001A |
|
71 |
71 |
$3K |
| 92587 |
|
78 |
78 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
192 |
190 |
$2K |
| 0072A |
|
45 |
45 |
$2K |
| 0002A |
|
44 |
44 |
$2K |
| 87634 |
|
31 |
30 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
482 |
473 |
$1K |
| 94760 |
|
457 |
450 |
$1K |
| 99173 |
|
46 |
46 |
$1K |
| 87081 |
|
148 |
147 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
25 |
24 |
$590.50 |
| 0154A |
|
12 |
12 |
$550.56 |
| 0054A |
|
12 |
12 |
$550.56 |
| 87807 |
|
26 |
26 |
$307.06 |
| 99000 |
|
119 |
117 |
$119.00 |
| 84703 |
|
13 |
13 |
$86.19 |